SEC Filing Summary: Predictive Oncology Inc. (POAI)
Business Context and Reporting Period
This Form 8-K was filed by Predictive Oncology Inc. on September 19, 2024. The company is incorporated in Delaware and its common stock trades on the NASDAQ Capital Market under the symbol "POAI". The filing addresses a regulatory notice regarding the company's continued listing status.
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial metric disclosed is the stock's bid price, which closed below $1.00 per share for 30 consecutive business days.
Material Changes and Listing Status
On September 19, 2024, the company received a notice from the Nasdaq Listing Qualifications Department stating it is not in compliance with the Minimum Bid Price Requirement (Rule 5550(a)(2)). This deficiency is due to the common stock closing below $1.00 per share for 30 consecutive business days. The notification has no immediate effect on the listing of the stock.
Outlook, Management Commentary, and Risks
- Compliance Period: The company has 180 calendar days, until March 18, 2025, to regain compliance.
- Compliance Criteria: To cure the deficiency, the bid price must close at or above $1.00 per share for a minimum of 10 consecutive business days before March 18, 2025.
- Alternative Options: If the company fails to regain compliance by the deadline, it may be eligible for an additional compliance period if it meets the market value of publicly held shares requirement and other initial listing standards. This may require a reverse stock split.
- Delisting Risk: If the company cannot cure the deficiency or is deemed ineligible for additional time, Nasdaq may delist the securities. The company may appeal such a determination, though there is no assurance of success.
- Management Action: Management intends to actively monitor the bid price and consider available options to resolve the deficiency.
Investor Verification Checklist
- Verify the current trading price of POAI to assess proximity to the $1.00 threshold.
- Monitor the company's stock price performance over the next 10 consecutive business days to determine if immediate compliance is achieved.
- Review future filings for announcements regarding a potential reverse stock split if the March 18, 2025 deadline approaches without compliance.
- Check for any subsequent Nasdaq notifications regarding the denial of additional compliance time or delisting proceedings.